🇺🇸 FDA
Patent

US 9181277

Aminoquinazoline derivatives and their salts and methods of use

granted A61KA61K31/517A61K31/519

Quick answer

US patent 9181277 (Aminoquinazoline derivatives and their salts and methods of use) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/517, A61K31/519, A61K31/5383, A61K45/06